Synthesis, biochemical evaluation and molecular modeling studies of novel rhodium complexes with nanomolar activity against Platelet Activating Factor
Authors:
- Alexandros B. TsouprasAlexandros B. Tsoupras
- Athanasios PapakyriakouAthanasios Papakyriakou
- Constantinos A. DemopoulosCDConstantinos A. Demopoulos
- Athanassios I. PhilippopoulosAthanassios I. Philippopoulos
- 1 March 2013
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 120, 63-73
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in MelanomaMediators of Inflammation, 2012
- In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombinJournal of Inflammation, 2011
- Structurally Diverse Metal Coordination Compounds, Bearing Imidodiphosphinate and Diphosphinoamine Ligands, as Potential Inhibitors of the Platelet Activating FactorBioinorganic Chemistry and Applications, 2010
- Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma MetastasisJournal of Biological Chemistry, 2009
- Emerging Roles of PAR-1 and PAFR in Melanoma MetastasisCancer Microenvironment, 2008
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- A Simple Preparation of a Functionalized Diimine Ligand: 2-(2-Pyridyl)-4-CarboxyquinolineSynthetic Communications, 1997
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Platelet Activating Factor (PAF)Drugs, 1991
- Complexes of palladium, platinum and rhodium with 2,2?-biquinoline and 2-(2?-pyridyl)quinolineTransition Metal Chemistry, 1991